CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma

International Journal of Cancer

Volumn 134, Issue 10, 2014, Pages 2393-2402

  Fujii, Hiroko ^a   Arakawa, Akiko ^b   Utsumi, Daisuke ^c   Sumiyoshi, Shinji ^d   Yamamoto, Yosuke ^a   Kitoh, Akihiko ^a   Ono, Masahiro ^e   Matsumura, Yumi ^a   Kato, Mayumi ^a   Konishi, Keisuke ^f   Shiga, Takeo ^g   Sano, Shigetoshi ^g   Sakaguchi, Shimon ^h,i   Miyagawa Hayashino, Aya ^d   Takahashi, Kenzo ^c   Uezato, Hiroshi ^c   Miyachi, Yoshiki ^a   Tanioka, Miki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f KYOTO CITY HOSPITAL   (Japan)

^g KOCHI UNIVERSITY   (Japan)

^h KYOTO UNIVERSITY   (Japan)

ⁱ OSAKA UNIVERSITY   (Japan)

Author keywords

cutaneous angiosarcoma; prognosis; tumor infiltrating lymphocytes

Indexed keywords

GAMMA INTERFERON; KI 67 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER IMMUNOTHERAPY; CANCER STAGING; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR LOCALIZATION; VERY ELDERLY;

CUTANEOUS ANGIOSARCOMA; PROGNOSIS; TUMOR-INFILTRATING LYMPHOCYTES;

AGED; AGED, 80 AND OVER; ANTIGENS, CD4; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84895928445     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28581     Document Type: Article

References (37)

1. Young RJ, Brown NJ, Reed MW, et al. Angiosarcoma. Lancet Oncol 2010; 11: 983-91.
2. Maddox JC, Evans HL,. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer 1981; 48: 1907-21.
3. Furue M, Yamada N, Takahashi T, et al. Immunotherapy for Stewart-Treves syndrome. Usefulness of intrapleural administration of tumor-infiltrating lymphocytes against massive pleural effusion caused by metastatic angiosarcoma. J Am Acad Dermatol 1994; 30: 899-903.
4. Zietz C, Rumpler U, Sturzl M, et al. Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack. Am J Pathol 2001; 159: 963-70.
5. Rosenberg SA, Dudley ME,. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 2009; 21: 233-40.
6. Williams KM, Hakim FT, Gress RE,. T cell immune reconstitution following lymphodepletion. Semin Immunol 2007; 19: 318-30.
7. Nakai N, Hartmann G, Kishimoto S, et al. Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters. Pigment Cell Melanoma Res 2010; 23: 607-19.
8. Yu P, Fu YX,. Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 2006; 86: 231-45.
9. Gattinoni L, Powell DJ, Jr, Rosenberg SA, et al. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 2006; 6: 383-93.
10. Dunn GP, Dunn IF, Curry WT,. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun 2007; 7: 12.
11. Hiraoka N,. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol 2010; 15: 544-51.
12. Liakou CI, Narayanan S, Ng Tang D, et al. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immun 2007; 7: 10.
13. Oble DA, Loewe R, Yu P, et al. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 2009; 9: 3.
14. Ohtani H,. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 2007; 7: 4.
15. Uppaluri R, Dunn GP, Lewis JS, Jr,. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun 2008; 8: 16.
16. Nakano O, Sato M, Naito Y, et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001; 61: 5132-6.
17. Sato E, Olson SH, Ahn J, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 18538-43.
18. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-13.
19. Schumacher K, Haensch W, Roefzaad C, et al. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 2001; 61: 3932-6.
20. Wada Y, Nakashima O, Kutami R, et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 1998; 27: 407-14.
21. Wilke CM, Wu K, Zhao E, et al. Prognostic significance of regulatory T cells in tumor. Int J Cancer 2010; 127: 748-58.
22. Zou W,. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295-307.
23. Asagoe K, Otsuka M, Hamada T, et al. Treatment of angiosarcoma in Okayama University Hospital:analysis of 18 patients experienced in the past 15 years. Skin Cancer (Jpn) 2009; 24: 369-76.
24. Masuzawa M,. Angiosarcoma of the scalp: strategy and evaluation at Kitasato University Hospital. Skin Cancer (Jpn) 2009; 24: 377-84.
25. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
26. Toda Y, Kono K, Abiru H, et al. Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method. Pathol Int 1999; 49: 479-83.
27. Galon J, Pages F, Marincola FM, et al. Cancer classification using the Immunoscore: a worldwide task force. J Transl Med 2012; 10: 205.
28. Mukai S, Kjaergaard J, Shu S, et al. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res 1999; 59: 5245-9.
29. Willimsky G, Blankenstein T,. Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors. Cancer Res 2000; 60: 685-92.
30. Budhu S, Loike JD, Pandolfi A, et al. CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J Exp Med 2010; 207: 223-35.
31. Boon T, Coulie PG, Van den Eynde B,. Tumor antigens recognized by T cells. Immunol Today 1997; 18: 267-8.
32. Muul LM, Spiess PJ, Director EP, et al. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 1987; 138: 989-95.
33. Ayyoub M, Taub RN, Keohan ML, et al. The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. Cancer Immun 2004; 4: 7.
34. Dunn GP, Old LJ, Schreiber RD,. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22: 329-60.
35. Shurin MR, Lu L, Kalinski P, et al. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999; 21: 339-59.
36. Johansson M, Denardo DG, Coussens LM,. Polarized immune responses differentially regulate cancer development. Immunol Rev 2008; 222: 145-54.
37. Donghi D, Kerl K, Dummer R, et al. Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile. J Eur Acad Dermatol Venereol 2010; 24: 1230-4.